Hospitalizations from pandemic Influenza [A(H1N1)pdm09] infections among type 1 and 2 diabetes patients in Spain

被引:20
|
作者
Jimenez-Garcia, Rodrigo [1 ]
Hernandez-Barrera, Valentin [1 ]
Rodriguez-Rieiro, Cristina [1 ]
Lopez de Andres, Ana [1 ]
de Miguel-Diez, Javier [2 ]
Jimenez-Trujillo, Isabel [1 ]
Gil de Miguel, Angel [1 ]
Carrasco-Garrido, Pilar [1 ]
机构
[1] Rey Juan Carlos Univ, Prevent Med Unit, Madrid, Spain
[2] Hosp Gen Univ Gregorio Maranon, Dept Pneumol, Madrid, Spain
关键词
Diabetes; H1N1; hospitalizations; Influenza A; obesity; pandemic; CRITICALLY-ILL PATIENTS; 2009; H1N1; INFLUENZA; MORTALITY; OUTCOMES;
D O I
10.1111/j.1750-2659.2012.00419.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives To describe and analyze the clinical characteristics and outcomes for all patients with diabetes who were hospitalized with laboratory-confirmed A(H1N1)pdm09 infections in Spain during 2009. Methods Observational retrospective study using data collected by the Spanish National Hospital Discharge Database. We selected all admissions with diagnosis ICD-9-CM code 488 center dot 1 [A(H1N1)pdm09]. Discharges were grouped as follows: no diabetes, Type1 and Type 2 diabetes. Underlying medical conditions and risk factors included all those that constitute an indication for annual influenza vaccination, pregnancy, and obesity. The outcome variables analyzed were in-hospital case fatality risk, length of hospital stay, and costs. Results The total number of persons hospitalized with A(H1N1)pdm09 was 11499. Of those, 97 suffered Type 1 and 936 Type 2, giving an overall prevalence of diabetes of 9%. The most common underlying medical condition among Type 2 subjects was obesity (26 center dot 8%), and for Type 1 renal disease (10 center dot 3%). In-hospital mortality was 2 center dot 1% among Type 1 patients, 3 center dot 8% among Type 2 patients, and 2 center dot 3% among non-diabetics; after multivariate analysis, diabetes was not a factor independently associated with dying during hospitalization for A(H1N1)pdm09. Independent factors increasing the risk of death among diabetic patients included age (OR 1 center dot 03; 95% CI1 center dot 011 center dot 05), hematological disorders (OR 3 center dot 49; 95% CI, 1 center dot 468 center dot 37), and obesity (OR 1 center dot 88; 95% CI1 center dot 073 center dot 92). Conclusions Among individuals hospitalized in Spain with A(H1N1)pdm09 infections, the age-specific prevalence of diabetes was higher than the general population in most age groups. The results of multivariate analysis suggest that possibly concomitant conditions such as obesity increase the risk of dying from the infection, but not diabetes itself.
引用
收藏
页码:439 / 447
页数:9
相关论文
共 50 条
  • [41] Counting pandemic deaths: comparing reported numbers of deaths from influenza A(H1N1)pdm09 with estimated excess mortality
    Gran, Jon Michael
    Kacelnik, Oliver
    Grjibovski, Andrei M.
    Aavitsland, Preben
    Iversen, Bjorn G.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 (06) : 1370 - 1379
  • [42] Transmission routes of influenza A(H1N1) pdm09: analyses of inflight outbreaks
    Lei, H.
    Tang, J. W.
    Lie, Y.
    EPIDEMIOLOGY AND INFECTION, 2018, 146 (13) : 1731 - 1739
  • [43] Molecular and epidemiological analysis of pandemic and post-pandemic influenza A(H1N1)pdm09 virus from central India
    Sahu, Mahima
    Singh, Neeru
    Shukla, Mohan K.
    Potdar, Varhsa A.
    Sharma, Ravendra K.
    Sahare, Lalit Kumar
    Ukey, Mahendra J.
    Barde, Pradip V.
    JOURNAL OF MEDICAL VIROLOGY, 2018, 90 (03) : 447 - 455
  • [44] Sequence-based identification and characterization of nosocomial influenza A(H1N1)pdm09 virus infections
    Jonges, M.
    Rahamat-Langendoen, J.
    Meijer, A.
    Niesters, H. G.
    Koopmans, M.
    JOURNAL OF HOSPITAL INFECTION, 2012, 82 (03) : 187 - 193
  • [45] Plasma cytokine levels and cytokine gene polymorphisms in Mexican patients during the influenza pandemic A(H1N1)pdm09
    Martinez-Ocana, Joel
    Olivo-Diaz, Angelica
    Salazar-Dominguez, Tobias
    Reyes-Gordillo, Jesus
    Tapia-Aquino, Cynthia
    Martinez-Hernandez, Fernando
    Eugenia Manjarrez, Maria
    Antonio-Martinez, Marco
    Contreras-Molina, Araceli
    Figueroa-Moreno, Rafael
    Valdez-Vazquez, Rafael
    Kawa-Karasik, Simon
    Rodriguez-Zulueta, Patricia
    Flisser, Ana
    Maravilla, Pablo
    Romero-Valdovinos, Mirza
    JOURNAL OF CLINICAL VIROLOGY, 2013, 58 (01) : 108 - 113
  • [46] The first, second and third wave of pandemic influenza A (H1N1)pdm09 in North Denmark Region 2009-2011: a population-based study of hospitalizations
    Orsted, Iben
    Molvadgaard, Mette
    Nielsen, Hans Linde
    Nielsen, Henrik
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 (05) : 776 - 782
  • [47] Characteristics of Hospitalized Cases with Influenza A (H1N1) pdm09 Infection during First Winter Season of Post-Pandemic in China
    Xu, Cuiling
    Iuliano, A. Danielle
    Chen, Min
    Cheng, Po-Yung
    Chen, Tao
    Shi, Jinghong
    Yang, Jing
    Wang, Lijie
    Yuan, Fan
    Widdowson, Marc-Alain
    Shu, Yuelong
    PLOS ONE, 2013, 8 (02):
  • [48] ACUTE RESPIRATORY DISTRESS SYNDROME SECONDARY TO INFLUENZA A(H1N1)PDM09: CLINICAL CHARACTERISTICS AND MORTALITY PREDICTORS
    Margarita Hernandez-Cardenas, Carmen
    Serna-Secundino, Hector
    Guadalupe Garcia-Olazaran, Jose
    Leticia Aguilar-Perez, Cristina
    Rocha-Machado, Jesus
    Fernando Campos-Calderon, Luis
    Lugo-Goytia, Gustavo
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2016, 68 (05): : 235 - 244
  • [49] The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09
    MacIntyre, Chandini Raina
    Chughtai, Abrar Ahmad
    Barnes, Michelle
    Ridda, Iman
    Seale, Holly
    Toms, Renin
    Heywood, Anita
    BMC INFECTIOUS DISEASES, 2018, 18
  • [50] Key points in evaluating immunogenicity of pandemic influenza vaccines: A lesson from immunogenicity studies of influenza A(H1N1) pdm09 vaccine
    Ohfuji, Satoko
    Kobayashi, Masayuki
    Ide, Yuichiro
    Egawa, Yumi
    Saito, Tomoko
    Kondo, Kyoko
    Ito, Kazuya
    Kase, Tetsuo
    Maeda, Akiko
    Fukushima, Wakaba
    Hirota, Yoshio
    VACCINE, 2017, 35 (39) : 5303 - 5308